Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quentin M Anstee

Showing results (201-210 of 262) with videos related to

Pageof 27
Sort By:
Nature|July 6, 2018
Author Correction: Inflammation-induced IgA<sup>+</sup> cells dismantle anti-liver cancer immunityShabnam Shalapour, Xue-Jia Lin, Ingmar N Bastian, et al.
Cardiovascular Diabetology|July 29, 2021
A molecular signature for the metabolic syndrome by urine metabolomicsChiara Bruzzone, Rubén Gil-Redondo, Marisa Seco, et al.
The Lancet. Gastroenterology & Hepatology|February 7, 2020
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation studyPhilip N Newsome, Magali Sasso, Jonathan J Deeks, et al.
Journal of Hepatology|January 29, 2022
Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLDElizabeth M Brunt, Andrew D Clouston, Zachary Goodman, et al.
Nature|November 17, 2017
Inflammation-induced IgA+ cells dismantle anti-liver cancer immunityShabnam Shalapour, Xue-Jia Lin, Ingmar N Bastian, et al.
Journal of Hepatology|July 30, 2023
Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitisArun J Sanyal, Vlad Ratziu, Rohit Loomba, et al.
JHEP Reports : Innovation in Hepatology|January 16, 2023
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practiceJeffrey V Lazarus, Laurent Castera, Henry E Mark, et al.
Nature|November 24, 2017
Erratum: Inflammation-induced IgA<sup>+</sup> cells dismantle anti-liver cancer immunityShabnam Shalapour, Xue-Jia Lin, Ingmar N Bastian, et al.
Hepatology (Baltimore, Md.)|July 5, 2019
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR TrialsQuentin M Anstee, Eric J Lawitz, Naim Alkhouri, et al.
Scientific Reports|July 5, 2017
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individualsBenedetta Donati, Paola Dongiovanni, Stefano Romeo, et al.
Pageof 27

Showing results (201-210 of 262) with videos related to

Sort By:
Pageof 27
Nature|July 6, 2018
Author Correction: Inflammation-induced IgA<sup>+</sup> cells dismantle anti-liver cancer immunityShabnam Shalapour, Xue-Jia Lin, Ingmar N Bastian, et al.
Cardiovascular Diabetology|July 29, 2021
A molecular signature for the metabolic syndrome by urine metabolomicsChiara Bruzzone, Rubén Gil-Redondo, Marisa Seco, et al.
The Lancet. Gastroenterology & Hepatology|February 7, 2020
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation studyPhilip N Newsome, Magali Sasso, Jonathan J Deeks, et al.
Journal of Hepatology|January 29, 2022
Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLDElizabeth M Brunt, Andrew D Clouston, Zachary Goodman, et al.
Nature|November 17, 2017
Inflammation-induced IgA+ cells dismantle anti-liver cancer immunityShabnam Shalapour, Xue-Jia Lin, Ingmar N Bastian, et al.
Journal of Hepatology|July 30, 2023
Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitisArun J Sanyal, Vlad Ratziu, Rohit Loomba, et al.
JHEP Reports : Innovation in Hepatology|January 16, 2023
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practiceJeffrey V Lazarus, Laurent Castera, Henry E Mark, et al.
Nature|November 24, 2017
Erratum: Inflammation-induced IgA<sup>+</sup> cells dismantle anti-liver cancer immunityShabnam Shalapour, Xue-Jia Lin, Ingmar N Bastian, et al.
Hepatology (Baltimore, Md.)|July 5, 2019
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR TrialsQuentin M Anstee, Eric J Lawitz, Naim Alkhouri, et al.
Scientific Reports|July 5, 2017
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individualsBenedetta Donati, Paola Dongiovanni, Stefano Romeo, et al.
Pageof 27